{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:45:02Z","timestamp":1785818702145,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","award":["KGM1062511"],"award-info":[{"award-number":["KGM1062511"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The development of human-relevant in vitro cardiac models is essential for evaluating cardiotoxicity and drug efficacy. Although wingless-related integration site signaling-based protocols have enabled cardiomyocyte (CM) differentiation from pluripotent stem cells, issues such as low efficiency, immature phenotype, and variability across cell lines remain to be resolved. Here, we present an improved differentiation strategy that robustly enhances both the efficiency and functional maturity of CMs, comparable to the functional characteristics of human adult myocardial tissue. Although fetal bovine serum enhanced differentiation, we disclosed that the interaction between sphingosine-1-phosphate (S1P) and its receptor S1PR1 is a major contributor. Gene-based and protein-based analyses and electrophysiological analysis via multielectrode array confirmed that activation of S1PR1 using S1P or its agonist SEW2871 increased the generation of spontaneously beating CMs, whereas S1PR1-deficient pluripotent stem cells exhibited impaired differentiation and functional maturity of S1P-S1PR1-derived CMs. Furthermore, we observed improved cardiac function and reduced fibrosis in a myocardial infarction mouse model induced by left descending artery ligation following transplantation of CMs differentiated more robustly by treatment with S1P or SEW2871. Collectively, S1PR1 activator-treated CMs offer a cost-effective platform for drug discovery and regenerative medicine.<\/jats:p>","DOI":"10.1038\/s12276-026-01767-3","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:13:05Z","timestamp":1782990785000},"page":"2223-2234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sphingosine-1-phosphate receptor 1 signaling stimulates human pluripotent stem cell-derived cardiomyocyte differentiation and maturation"],"prefix":"10.1038","volume":"58","author":[{"given":"Won Dong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul-Gi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Bo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ae","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Seul","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7782-5711","authenticated-orcid":false,"given":"Hana","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8242-9390","authenticated-orcid":false,"given":"Hyun-Soo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4999-1613","authenticated-orcid":false,"given":"Dae-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongman","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Ok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-5360","authenticated-orcid":false,"given":"Ohman","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-8812","authenticated-orcid":false,"given":"Mi-Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"1767_CR1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nat Methods 11, 855\u2013860 (2014).","journal-title":"Nat Methods"},{"key":"1767_CR2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.1582-4934.2012.01528.x","volume":"16","author":"J Jiang","year":"2012","unstructured":"Jiang, J., Han, P., Zhang, Q., Zhao, J. & Ma, Y. Cardiac differentiation of human pluripotent stem cells. J Cell Mol Med 16, 1663\u20131668 (2012).","journal-title":"J Cell Mol Med"},{"key":"1767_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI200112131","volume":"108","author":"I Kehat","year":"2001","unstructured":"Kehat, I. et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108, 407\u2013414 (2001).","journal-title":"J Clin Invest"},{"key":"1767_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05652-y","volume":"7","author":"Z Laksman","year":"2017","unstructured":"Laksman, Z. et al. Modeling atrial fibrillation using human embryonic stem cell-derived atrial tissue. Sci Rep 7, 5268 (2017).","journal-title":"Sci Rep"},{"key":"1767_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.stem.2016.07.006","volume":"19","author":"E Matsa","year":"2016","unstructured":"Matsa, E. et al. Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro. Cell Stem Cell 19, 311\u2013325 (2016).","journal-title":"Cell Stem Cell"},{"key":"1767_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09831-5","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors. Nat Commun 10, 2238 (2019).","journal-title":"Nat Commun"},{"key":"1767_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23329-z","volume":"12","author":"S Funakoshi","year":"2021","unstructured":"Funakoshi, S. et al. Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells. Nat Commun 12, 3155 (2021).","journal-title":"Nat Commun"},{"key":"1767_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12015-014-9564-6","volume":"11","author":"A Kadari","year":"2015","unstructured":"Kadari, A. et al. Robust generation of cardiomyocytes from human iPS cells requires precise modulation of BMP and WNT signaling. Stem Cell Rev Rep 11, 560\u2013569 (2015).","journal-title":"Stem Cell Rev Rep"},{"key":"1767_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fcell.2019.00164","volume":"7","author":"A Leitolis","year":"2019","unstructured":"Leitolis, A., Robert, A. W., Pereira, I. T., Correa, A. & Stimamiglio, M. A. Cardiomyogenesis modeling using pluripotent stem cells: the role of microenvironmental signaling. Front Cell Dev Biol 7, 164 (2019).","journal-title":"Front Cell Dev Biol"},{"key":"1767_CR10","doi-asserted-by":"publisher","first-page":"e69028","DOI":"10.7554\/eLife.69028","volume":"11","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Cardiac differentiation of human pluripotent stem cells using defined extracellular matrix proteins reveals essential role of fibronectin. eLife 11, e69028 (2022).","journal-title":"eLife"},{"key":"1767_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/biores.2014.0018","volume":"3","author":"S Sa","year":"2014","unstructured":"Sa, S., Wong, L. & McCloskey, K. E. Combinatorial fibronectin and laminin signaling promote highly efficient cardiac differentiation of human embryonic stem cells. Biores Open Access 3, 150\u2013161 (2014) .","journal-title":"Biores Open Access"},{"key":"1767_CR12","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1089\/scd.2014.0533","volume":"24","author":"CC Veerman","year":"2015","unstructured":"Veerman, C. C. et al. Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem? Stem Cells Dev 24, 1035\u20131052 (2015).","journal-title":"Stem Cells Dev"},{"key":"1767_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1039\/C7MB00174F","volume":"13","author":"KB Jung","year":"2017","unstructured":"Jung, K. B. et al. Transcriptome dynamics of human pluripotent stem cell-derived contracting cardiomyocytes using an embryoid body model with fetal bovine serum. Mol Biosyst 13, 1565\u20131574 (2017).","journal-title":"Mol Biosyst"},{"key":"1767_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tips.2013.05.002","volume":"34","author":"C O\u2019Sullivan","year":"2013","unstructured":"O\u2019Sullivan, C. & Dev, K. K. The structure and function of the S1P1 receptor. Trends Pharmacol Sci 34, 401\u2013412 (2013).","journal-title":"Trends Pharmacol Sci"},{"key":"1767_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cmet.2024.01.017","volume":"36","author":"X Ji","year":"2024","unstructured":"Ji, X. et al. Sphingolipid metabolism controls mammalian heart regeneration. Cell Metab 36, 839\u2013856.e8 (2024).","journal-title":"Cell Metab"},{"key":"1767_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/35018092","volume":"406","author":"E Kupperman","year":"2000","unstructured":"Kupperman, E., An, S., Osborne, N., Waldron, S. & Stainier, D. Y. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature 406, 192\u2013195 (2000).","journal-title":"Nature"},{"key":"1767_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tibs.2010.08.001","volume":"36","author":"SM Pitson","year":"2011","unstructured":"Pitson, S. M. Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem Sci 36, 97\u2013107 (2011).","journal-title":"Trends Biochem Sci"},{"key":"1767_CR18","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.phrs.2020.104793","volume":"156","author":"E Jozefczuk","year":"2020","unstructured":"Jozefczuk, E., Guzik, T. J. & Siedlinski, M. Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology. Pharmacol Res 156, 104793 (2020).","journal-title":"Pharmacol Res"},{"key":"1767_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/cvr\/cvp086","volume":"82","author":"CK Means","year":"2009","unstructured":"Means, C. K. & Brown, J. H. Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res 82, 193\u2013200 (2009).","journal-title":"Cardiovasc Res"},{"key":"1767_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05450-8","volume":"9","author":"KB Jung","year":"2018","unstructured":"Jung, K. B. et al. Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids. Nat Commun 9, 3039 (2018).","journal-title":"Nat Commun"},{"key":"1767_CR21","doi-asserted-by":"crossref","unstructured":"Kwon, O. et al. The development of a functional human small intestinal epithelium model for drug absorption. Sci Adv 7 (2021).","DOI":"10.1126\/sciadv.abh1586"},{"key":"1767_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115696","volume":"428","author":"SA Hyun","year":"2021","unstructured":"Hyun, S. A. et al. Cardiac toxicity from bisphenol A exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol 428, 115696 (2021).","journal-title":"Toxicol Appl Pharmacol"},{"key":"1767_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1649-6","volume":"16","author":"GR Guo","year":"2018","unstructured":"Guo, G. R. et al. A modified method for isolation of human cardiomyocytes to model cardiac diseases. J Transl Med 16, 288 (2018).","journal-title":"J Transl Med"},{"key":"1767_CR24","unstructured":"Zeller, R. Fixation, embedding, and sectioning of tissues, embryos, and single cells. Curr Protoc Mol Biol 14, Unit 14.1 (2001)."},{"key":"1767_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100775","volume":"2","author":"K Maruyama","year":"2021","unstructured":"Maruyama, K. et al. Surgical protocol for permanent ligation of the left anterior descending coronary artery in mice to generate a model of myocardial infarction. STAR Protoc 2, 100775 (2021).","journal-title":"STAR Protoc"},{"key":"1767_CR26","doi-asserted-by":"publisher","first-page":"e2307353","DOI":"10.1002\/advs.202307353","volume":"11","author":"J Lee","year":"2024","unstructured":"Lee, J. et al. Paintable decellularized-ECM hydrogel for preventing cardiac tissue damage. Adv Sci (Weinh) 11, e2307353 (2024).","journal-title":"Adv Sci (Weinh)"},{"key":"1767_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1293\/tox.22.83","volume":"22","author":"T Suzuki","year":"2009","unstructured":"Suzuki, T. et al. Spontaneous cardiac hypertrophy in a Crl:CD(SD) rat. J Toxicol Pathol 22, 83\u201387 (2009).","journal-title":"J Toxicol Pathol"},{"key":"1767_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5152\/akd.2015.5875","volume":"15","author":"C Rezus","year":"2015","unstructured":"Rezus, C., Moga, V. D., Ouatu, A. & Floria, M. QT interval variations and mortality risk: is there any relationship? Anatol J Cardiol 15, 255\u2013258 (2015).","journal-title":"Anatol J Cardiol"},{"key":"1767_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48174-5","volume":"9","author":"HB Hayes","year":"2019","unstructured":"Hayes, H. B. et al. Novel method for action potential measurements from intact cardiac monolayers with multiwell microelectrode array technology. Sci Rep 9, 11893 (2019).","journal-title":"Sci Rep"},{"key":"1767_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-1889-y","volume":"5","author":"J Kuusela","year":"2016","unstructured":"Kuusela, J. et al. Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes. Springerplus 5, 234 (2016).","journal-title":"Springerplus"},{"key":"1767_CR31","doi-asserted-by":"publisher","first-page":"e103485","DOI":"10.1371\/journal.pone.0103485","volume":"9","author":"A Mehta","year":"2014","unstructured":"Mehta, A. et al. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells. PLoS ONE 9, e103485 (2014).","journal-title":"PLoS ONE"},{"key":"1767_CR32","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.stemcr.2018.04.006","volume":"10","author":"N Shaheen","year":"2018","unstructured":"Shaheen, N. et al. Human induced pluripotent stem cell-derived cardiac cell sheets expressing genetically encoded voltage indicator for pharmacological and arrhythmia studies. Stem Cell Rep 10, 1879\u20131894 (2018).","journal-title":"Stem Cell Rep"},{"key":"1767_CR33","first-page":"21.23.21","volume":"87","author":"PW Burridge","year":"2015","unstructured":"Burridge, P. W., Holmstrom, A. & Wu, J. C. Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells. Curr Protoc Hum Genet 87, 21.23.21\u201321.23.15 (2015).","journal-title":"Curr Protoc Hum Genet"},{"key":"1767_CR34","first-page":"613","volume":"41","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y., Park, P., Hong, S. M. & Ban, K. Maturation of cardiomyocytes derived from human pluripotent stem cells: current strategies and limitations. Mol Cells 41, 613\u2013621 (2018).","journal-title":"Mol Cells"},{"key":"1767_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/scrt507","volume":"5","author":"R Zhu","year":"2014","unstructured":"Zhu, R. et al. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 5, 117 (2014).","journal-title":"Stem Cell Res Ther"},{"key":"1767_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yjmcc.2014.12.003","volume":"80","author":"F Laco","year":"2015","unstructured":"Laco, F. et al. Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling. J Mol Cell Cardiol 80, 56\u201370 (2015).","journal-title":"J Mol Cell Cardiol"},{"key":"1767_CR37","doi-asserted-by":"publisher","first-page":"11956","DOI":"10.1073\/pnas.1713763114","volume":"114","author":"T Wu","year":"2017","unstructured":"Wu, T. et al. HSPB7 is indispensable for heart development by modulating actin filament assembly. Proc Natl Acad Sci USA 114, 11956\u201311961 (2017).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1767_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrcardio.2014.188","volume":"12","author":"RP Betgem","year":"2015","unstructured":"Betgem, R. P. et al. Intramyocardial haemorrhage after acute myocardial infarction. Nat Rev Cardiol 12, 156\u2013167 (2015).","journal-title":"Nat Rev Cardiol"},{"key":"1767_CR39","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0195-5616(85)50364-2","volume":"15","author":"JD Bonagura","year":"1985","unstructured":"Bonagura, J. D., O\u2019Grady, M. R. & Herring, D. S. Echocardiography. Principles of interpretation. Vet Clin North Am Small Anim Pract 15, 1177\u20131194 (1985).","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"1767_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jep.2014.07.012","volume":"158","author":"H Maegawa","year":"2014","unstructured":"Maegawa, H., Nakamura, T. & Saito, K. Regulation of traditional herbal medicinal products in Japan. J Ethnopharmacol 158, 511\u2013515 (2014).","journal-title":"J Ethnopharmacol"},{"key":"1767_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/026119290203000208","volume":"30","author":"CE Jochems","year":"2002","unstructured":"Jochems, C. E., van der Valk, J. B., Stafleu, F. R. & Baumans, V. The use of fetal bovine serum: ethical or scientific problem? Altern Lab Anim 30, 219\u2013227 (2002).","journal-title":"Altern Lab Anim"},{"key":"1767_CR42","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjp.0705934","volume":"143","author":"AE Alewijnse","year":"2004","unstructured":"Alewijnse, A. E., Peters, S. L. & Michel, M. C. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. Br J Pharmacol 143, 666\u2013684 (2004).","journal-title":"Br J Pharmacol"},{"key":"1767_CR43","doi-asserted-by":"publisher","first-page":"H736","DOI":"10.1152\/ajpheart.00316.2007","volume":"294","author":"LK Landeen","year":"2008","unstructured":"Landeen, L. K. et al. Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes. Am J Physiol Heart Circ Physiol 294, H736\u2013H749 (2008).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1767_CR44","doi-asserted-by":"publisher","first-page":"H3150","DOI":"10.1152\/ajpheart.00587.2006","volume":"293","author":"J Zhang","year":"2007","unstructured":"Zhang, J. et al. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol 293, H3150\u2013H3158 (2007).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1767_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mce.2006.03.017","volume":"252","author":"A Keren","year":"2006","unstructured":"Keren, A., Tamir, Y. & Bengal, E. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol Cell Endocrinol 252, 224\u2013230 (2006).","journal-title":"Mol Cell Endocrinol"},{"key":"1767_CR46","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1172\/JCI71194","volume":"124","author":"M Kono","year":"2014","unstructured":"Kono, M. et al. Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo. J Clin Invest 124, 2076\u20132086 (2014).","journal-title":"J Clin Invest"},{"key":"1767_CR47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1172\/JCI10905","volume":"106","author":"Y Liu","year":"2000","unstructured":"Liu, Y. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106, 951\u2013961 (2000).","journal-title":"J Clin Invest"},{"key":"1767_CR48","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","volume":"25","author":"K Mizugishi","year":"2005","unstructured":"Mizugishi, K. et al. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25, 11113\u201311121 (2005).","journal-title":"Mol Cell Biol"},{"key":"1767_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ydbio.2016.06.024","volume":"418","author":"H Clay","year":"2016","unstructured":"Clay, H. et al. Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development. Dev Biol 418, 157\u2013165 (2016).","journal-title":"Dev Biol"},{"key":"1767_CR50","doi-asserted-by":"publisher","first-page":"10454","DOI":"10.1073\/pnas.180316397","volume":"97","author":"JS Mudgett","year":"2000","unstructured":"Mudgett, J. S. et al. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97, 10454\u201310459 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1767_CR51","doi-asserted-by":"crossref","unstructured":"Romero-Becerra, R., Santamans, A.M., Folgueira, C. & Sabio, G. p38 MAPK pathway in the heart: new insights in health and disease. Int J Mol Sci 21 (2020).","DOI":"10.3390\/ijms21197412"},{"key":"1767_CR52","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1634\/stemcells.2005-0398","volume":"24","author":"M Aouadi","year":"2006","unstructured":"Aouadi, M. et al. p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells 24, 1399\u20131406 (2006).","journal-title":"Stem Cells"},{"key":"1767_CR53","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1038\/sj.onc.1206608","volume":"22","author":"J Hernandez Losa","year":"2003","unstructured":"Hernandez Losa, J. et al. Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene 22, 3998\u20134006 (2003).","journal-title":"Oncogene"},{"key":"1767_CR54","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13287-023-03468-4","volume":"14","author":"Y Tanaka","year":"2023","unstructured":"Tanaka, Y. et al. Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin. Stem Cell Res Ther 14, 240 (2023).","journal-title":"Stem Cell Res Ther"},{"key":"1767_CR55","doi-asserted-by":"publisher","first-page":"e0173222","DOI":"10.1371\/journal.pone.0173222","volume":"12","author":"SV Rojas","year":"2017","unstructured":"Rojas, S. V. et al. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction. PLoS ONE 12, e0173222 (2017).","journal-title":"PLoS ONE"},{"key":"1767_CR56","doi-asserted-by":"publisher","first-page":"e107363","DOI":"10.1371\/journal.pone.0107363","volume":"9","author":"V Lepperhof","year":"2014","unstructured":"Lepperhof, V. et al. Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients. PLoS ONE 9, e107363 (2014).","journal-title":"PLoS ONE"},{"key":"1767_CR57","first-page":"114","volume":"55","author":"D Sharma","year":"2026","unstructured":"Sharma, D. et al. Human iPSC-derived cardiac-specific extracellular matrix scaffolds for cardiomyocyte maturation and post-myocardial infarction repair. Bioact Mater 55, 114\u2013130 (2026).","journal-title":"Bioact Mater"},{"key":"1767_CR58","first-page":"0161","volume":"6","author":"X Song","year":"2023","unstructured":"Song, X. et al. Cardiac-adaptive conductive hydrogel patch enabling construction of mechanical-electrical anisotropic microenvironment for heart repair. Research (Wash DC) 6, 0161 (2023).","journal-title":"Research (Wash DC)"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01767-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01767-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01767-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:08:58Z","timestamp":1785816538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01767-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01767-3","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}